# A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

> **NCT06554639** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** MK-5684
- **DRUG:** Prednisone
- **DRUG:** Fludrocortisone acetate
- **DRUG:** Diltiazem hydrocholoride

## Key facts

- **NCT ID:** NCT06554639
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-11
- **Primary completion:** 2024-08-05
- **Final completion:** 2024-08-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554639, "A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06554639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*